CLORICROMENE INHIBITS LEUKOTRIENE FORMATION BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY SUPPRESSING ARACHIDONATE RELEASE FROM MEMBRANE PHOSPHOLIPIDS

被引:18
作者
GRESELE, P
RIBALDI, E
MEZZASOMA, AM
QUERO, E
STASI, M
PROSDOCIMI, M
GORACCI, G
NENCI, GG
机构
[1] UNIV PERUGIA, INST BIOCHEM & MED CHEM, I-06100 PERUGIA, ITALY
[2] FIDIA RES LABS, ABANO TERME, ITALY
关键词
D O I
10.1016/0006-2952(93)90384-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cloricromene, an antithrombotic agent known to inhibit the release of arachidonic acid (AA) in stimulated human platelets, was tested for its effects on arachidonate release and metabolism in human polymorphonuclear leucocytes (PMNs). Cloricromene dose-dependently suppressed the release of leukotriene B4 (LTB4), as assessed by radioimmunoassay, from both isolated PMNs and human whole blood stimulated with the calcium ionophore A23187 or with serum-treated zymosan (STZ). The inhibitory effect was higher when the concentration of the stimulating agent was weaker. Cloricromene also inhibited dose-dependently the liberation of LTB4, LTC4, LTD4 and 5-hydroxy-6,8,11,14-eicosatetraenoic acid as assessed by HPLC in the supernatant of A23187-stimulated PMNs. Finally, the drug was able to suppress the release of [H-3]AA from purified human PMNs prelabelled with the radioactive fatty acid and stimulated with either A23187 or with STZ. The A23187-induced decrease in the radioactivity of phosphatidylinositol, the phospholipid class mainly involved in AA release in stimulated PMNs, was also inhibited by cloricromene. Cloricromene suppresses leukotriene formation in human PMNs by reducing AA release from membrane phospholipids, possibly through interference with phospholipase A2 activation; this activity may contribute to the leucocyte-inhibitory effects reported previously for cloricromene.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 41 条
[1]  
ABRAMSON SB, 1991, J IMMUNOL, V147, P231
[2]   EFFECTS OF 8-MONOCHLORO-3-BETA-DIETHYLAMINOETHYL-4-METHYL-7-ETHOXYCARBONYLMETHOXYCOUMARIN (AD6) ON CORONARY CIRCULATION IN DOG [J].
APORTI, F ;
FINESSO, M ;
GRANATA, L .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1978, 10 (05) :469-477
[3]   NEUTROPHIL DEPLETION SUPPRESSES IN-111-LABELED PLATELET ACCUMULATION IN INFARCTED MYOCARDIUM [J].
BEDNAR, M ;
SMITH, B ;
PINTO, A ;
MULLANE, KM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (05) :906-912
[4]  
BERTOCCHI F, 1989, N-S ARCH PHARMACOL, V339, P697
[5]   METABOLISM OF (C-14) ARACHIDONIC-ACID BY HUMAN PLATELETS [J].
BILLS, TK ;
SMITH, JB ;
SILVER, MJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 424 (02) :303-314
[6]  
BOMALASKI JS, 1989, J IMMUNOL, V142, P3957
[7]   NEW CONCEPTS IN THE MODULATION OF LEUKOTRIENE SYNTHESIS [J].
BORGEAT, P ;
DELACLOS, BF ;
MACLOUF, J .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (03) :381-387
[8]   SEPARATION OF WHITE BLOOD CELLS [J].
BOYUM, A .
NATURE, 1964, 204 (496) :793-&
[9]   RADIOIMMUNOASSAY OF LTB4 AND 6-TRANS LTB4 - ANALYTICAL AND PHARMACOLOGICAL CHARACTERIZATION OF IMMUNOREACTIVE LTB4 IN IONOPHORE STIMULATED HUMAN-BLOOD [J].
CAREY, F ;
FORDER, RA .
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1986, 22 (01) :57-70
[10]  
CHILTON FH, 1983, J BIOL CHEM, V258, P6357